Please Share:: 
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
HDIL
HDIL announced its 2QFY2012 consolidated numbers. The company’s net sales
increased by 15.4% yoy to `440cr (`382cr) in 2QFY2012. EBITDA for the quarter
declined by 12.1% yoy to `232cr (`260cr). OPM declined by 1543bp yoy to
52.7%, above our estimate of 49.7%. PAT for the quarter declined by 24.4% yoy to
`149cr, which was slightly below our estimate of `193cr. The decline in PAT can
largely be attributed to lower top line and margin compression during the quarter.
Currently, the stock is under review. We may revise our estimates and target price
post management interaction.
Anant Raj Industries
Anant Raj Industries announced its 2QFY2012 numbers. The company’s net sales
declined by 31.3% yoy to `91cr (`133cr), well below our estimate of `113cr.
EBITDA came in at `51cr, down 18.8% yoy, on the back of lower top line. OPM
expanded by 858bp yoy to 55.8%, which was above our estimate of 50.8%. PAT
declined by 27.8% yoy to `35cr, below our estimate of `40cr. The decline in PAT
can largely be attributed to lower top line during the quarter. Currently, the stock is
under review. We may revise our estimates and target price post management
interaction.
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
HDIL
HDIL announced its 2QFY2012 consolidated numbers. The company’s net sales
increased by 15.4% yoy to `440cr (`382cr) in 2QFY2012. EBITDA for the quarter
declined by 12.1% yoy to `232cr (`260cr). OPM declined by 1543bp yoy to
52.7%, above our estimate of 49.7%. PAT for the quarter declined by 24.4% yoy to
`149cr, which was slightly below our estimate of `193cr. The decline in PAT can
largely be attributed to lower top line and margin compression during the quarter.
Currently, the stock is under review. We may revise our estimates and target price
post management interaction.
Anant Raj Industries
Anant Raj Industries announced its 2QFY2012 numbers. The company’s net sales
declined by 31.3% yoy to `91cr (`133cr), well below our estimate of `113cr.
EBITDA came in at `51cr, down 18.8% yoy, on the back of lower top line. OPM
expanded by 858bp yoy to 55.8%, which was above our estimate of 50.8%. PAT
declined by 27.8% yoy to `35cr, below our estimate of `40cr. The decline in PAT
can largely be attributed to lower top line during the quarter. Currently, the stock is
under review. We may revise our estimates and target price post management
interaction.
No comments:
Post a Comment